Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 316,790Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2AMGEN CANADA INC

02 2APOTEX INC

03 2BIOSIMILAR COLLABORATIONS IRELAND LIMITED

04 2CELLTRION INC.

05 1HOFFMANN-LA ROCHE LIMITED

06 2PFIZER CANADA ULC

07 2SAMSUNG BIOEPIS CO., LTD

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : MVASI

Dosage Form : SOLUTION

Dosage Strength : 25MG/ML

Packaging :

Approval Date :

Application Number : 2470756

Regulatory Info : Prescription

Registration Country : Canada

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : MVASI

Dosage Form : SOLUTION

Dosage Strength : 25MG/ML

Packaging :

Approval Date :

Application Number : 2470748

Regulatory Info : Prescription

Registration Country : Canada

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : BAMBEVI

Dosage Form : SOLUTION

Dosage Strength : 100MG/4ML

Packaging :

Approval Date :

Application Number : 2520729

Regulatory Info : Prescription

Registration Country : Canada

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : BAMBEVI

Dosage Form : SOLUTION

Dosage Strength : 400MG/16ML

Packaging :

Approval Date :

Application Number : 2520737

Regulatory Info : Prescription

Registration Country : Canada

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : AVASTIN

Dosage Form : SOLUTION

Dosage Strength : 25MG/ML

Packaging : 4ML/16ML

Approval Date :

Application Number : 2270994

Regulatory Info : Prescription

Registration Country : Canada

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : ZIRABEV

Dosage Form : SOLUTION

Dosage Strength : 100MG/4ML

Packaging :

Approval Date :

Application Number : 2489430

Regulatory Info : Prescription

Registration Country : Canada

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : ZIRABEV

Dosage Form : SOLUTION

Dosage Strength : 400MG/16ML

Packaging :

Approval Date :

Application Number : 2489449

Regulatory Info : Prescription

Registration Country : Canada

blank

08

BIOSIMILAR COLLABORATIONS IRELAND LIMITE...

Country
2024 ACI Convention
Not Confirmed
arrow

BIOSIMILAR COLLABORATIONS IRELAND LIMITE...

Country
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : ABEVMY

Dosage Form : SOLUTION

Dosage Strength : 400MG/16ML

Packaging :

Approval Date :

Application Number : 2522160

Regulatory Info : Prescription

Registration Country : Canada

blank

09

BIOSIMILAR COLLABORATIONS IRELAND LIMITE...

Country
2024 ACI Convention
Not Confirmed
arrow

BIOSIMILAR COLLABORATIONS IRELAND LIMITE...

Country
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : ABEVMY

Dosage Form : SOLUTION

Dosage Strength : 100MG/4ML

Packaging :

Approval Date :

Application Number : 2522179

Regulatory Info : Prescription

Registration Country : Canada

blank

10

CELLTRION INC.

Country
2024 ACI Convention
Not Confirmed
arrow

CELLTRION INC.

Country
arrow
2024 ACI Convention
Not Confirmed

BEVACIZUMAB

Brand Name : VEGZELMA

Dosage Form : SOLUTION

Dosage Strength : 100MG/4ML

Packaging :

Approval Date :

Application Number : 2534177

Regulatory Info : Prescription

Registration Country : Canada

blank